Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug
Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug
Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal
Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal
Danaher buys patient monitoring specialist Masimo in $9.9B deal
Danaher buys patient monitoring specialist Masimo in $9.9B deal
Lilly pays CSL $100M upfront for IL-6 antibody that flunked a phase 3 organ transplant study
Lilly pays CSL $100M upfront for IL-6 antibody that flunked a phase 3 organ transplant study
Korsana crosses into crowded Alzheimer's field with $175M and anti-amyloid antibody
Korsana crosses into crowded Alzheimer's field with $175M and anti-amyloid antibody
Immunology CRO RoukenBio pens pact with AVS Bio for more predictable antibody development
Immunology CRO RoukenBio pens pact with AVS Bio for more predictable antibody development
Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering
Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering
Boehringer axes inhaled gene therapy after viewing cystic fibrosis data
Boehringer axes inhaled gene therapy after viewing cystic fibrosis data
Sanofi points to 'key opportunity' for Teva-partnered IBD in long-term data
Sanofi points to 'key opportunity' for Teva-partnered IBD in long-term data
Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push
Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push
Cyrano noses toward pivotal trial after midphase smell loss win
Cyrano noses toward pivotal trial after midphase smell loss win
Novocure gets FDA nod for tumor-treating electric fields targeting pancreatic cancer
Novocure gets FDA nod for tumor-treating electric fields targeting pancreatic cancer
Gilead’s latest synthetic lethal therapy comes via $1.5B deal with China’s Genhouse
Gilead’s latest synthetic lethal therapy comes via $1.5B deal with China’s Genhouse
Biopharma funding to experience 'continued, albeit disciplined' recovery in 2026: PitchBook
Biopharma funding to experience 'continued, albeit disciplined' recovery in 2026: PitchBook
'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments
'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments
FDA rejects Disc's rare disease drug despite commissioner's voucher
FDA rejects Disc's rare disease drug despite commissioner's voucher
With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page Thermo Fisher Core Tools & Instruments
Track Danaher Core Tools & Instruments
Track Agilent Core Tools & Instruments
Track Merck KGaA Core Tools & Instruments
Track Illumina Core Tools & Instruments
Track Waters Core Tools & Instruments
Track Bruker Core Tools & Instruments
Track Sartorius Core Tools & Instruments
Track Mettler Toledo Core Tools & Instruments
Track PerkinElmer (Revvity) Core Tools & Instruments
Track Bio-Rad Core Tools & Instruments
Track Carl Zeiss Core Tools & Instruments
Track Leica Microsystems Core Tools & Instruments
Track Nikon Core Tools & Instruments
Track Eppendorf Core Tools & Instruments
Track Corning Core Tools & Instruments
Track BD (Becton Dickinson) Core Tools & Instruments
Track Beckman Coulter Core Tools & Instruments
Track Qiagen Core Tools & Instruments
Track Abcam Core Tools & Instruments
Track MGI Tech (华大智造) Core Tools & Instruments
Track Haier Biomedical Core Tools & Instruments
Track Lonza Outsourcing Services (CRO / CDMO)
Track WuXi AppTec (药明康德) Outsourcing Services (CRO / CDMO)
Track WuXi Biologics Outsourcing Services (CRO / CDMO)
Track Charles River Outsourcing Services (CRO / CDMO)
Track Catalent Outsourcing Services (CRO / CDMO)
Track Samsung Biologics Outsourcing Services (CRO / CDMO)
Track IQVIA Outsourcing Services (CRO / CDMO)
Track LabCorp Outsourcing Services (CRO / CDMO)
Track Eurofins Outsourcing Services (CRO / CDMO)
Track Pharmaron (康龙化成) Outsourcing Services (CRO / CDMO)
Track Pfizer Pharma, Biotech & AI
Track Roche Pharma, Biotech & AI
Track Merck & Co. (MSD) Pharma, Biotech & AI
Track Novartis Pharma, Biotech & AI
Track Eli Lilly Pharma, Biotech & AI
Track Novo Nordisk Pharma, Biotech & AI
Track Moderna Pharma, Biotech & AI
Track BioNTech Pharma, Biotech & AI
Track Amgen Pharma, Biotech & AI
Track BeiGene (百济神州) Pharma, Biotech & AI
Track Vertex Pharma, Biotech & AI
Track Schrödinger Pharma, Biotech & AI
Track Recursion Pharma, Biotech & AI
Track Exscientia Pharma, Biotech & AI
Track Insilico Medicine Pharma, Biotech & AI
Track XtalPi (晶泰科技) Pharma, Biotech & AI
Track NVIDIA Healthcare Pharma, Biotech & AI
Track DeepMind (Google) Pharma, Biotech & AI
Track Medtronic MedTech & Diagnostics
Track Siemens Healthineers MedTech & Diagnostics
Track GE HealthCare MedTech & Diagnostics
Track Philips MedTech & Diagnostics
Track Abbott MedTech & Diagnostics
Track Intuitive Surgical MedTech & Diagnostics
Track Boston Scientific MedTech & Diagnostics
Track Edwards Lifesciences MedTech & Diagnostics
Track Mindray (迈瑞) MedTech & Diagnostics
Track United Imaging (联影) MedTech & Diagnostics
Track Sysmex MedTech & Diagnostics
Track Hologic MedTech & Diagnostics
Track